## Note
nid: 1497215299862
model: AnKingOverhaul
tags: #AK_Original_Decks::Step_1::Zanki_Pharmacology, #AK_Step1_v11::#FirstAid::02_Immunology::04_Immunosuppressants::04_Therapeutic_Antibodies, #AK_Step1_v11::#FirstAid::02_Immunology::04_Immunosuppressants::04_Therapeutic_Antibodies::Canakinumab, #AK_Step1_v11::#OME_banner::Basic_Science::07_Immunology, #AK_Step1_v11::#Pixorize::01_Immunology::05_Cytokines::02_IL-1, #AK_Step1_v11::#SketchyPharm::Miscellaneous_Pharm, #AK_Step1_v11::^Other::^EXPN, #AK_Step1_v11::^Other::^HighYield::4-LowerYield, #AK_Step1_v11::^Systems::Musculoskeletal::Pharmacology
markdown: false

### Text
<div>
  <div>
    <b>Canakinumab</b> is a <u>biologic</u> that binds and prevents
    the activity of IL-{{c1::<b>1B</b>}}
  </div>
</div>

### Extra
<i>IL-1B (besides TNFa) is the most important <b>proinflammatory
cytokine</b>, which is released due to stimulation of the
inflammasome</i>
<div>
  <i><img src="paste-7675106557953.jpg"></i>
</div>

### Lecture Notes


### Missed Questions


### Pathoma


### Boards and Beyond


### First Aid


### Sketchy


### Pixorize


### Physeo


### OME
<div class="ome-widget">
  <a href=
  "https://onlinemeded.org/spa/immunology?ref=anki"><img src=
  "_OME_AnkiFlashcards_Topic_1.png"></a>
</div>

### Additional Resources


### One by one

